Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Regulations Under the Federal Import Milk Act, 34670-34672 [2015-14888]
Download as PDF
asabaliauskas on DSK5VPTVN1PROD with NOTICES
34670
Federal Register / Vol. 80, No. 116 / Wednesday, June 17, 2015 / Notices
Quantitative Review,’’ PLoS One,
5(3):e9434, 2010.
31. Ascherio, A., M. B. Katan, P. L. Zock, et
al., ‘‘Trans Fatty Acids and Coronary
Heart Disease,’’ New England Journal of
Medicine, 340:1994–1998, 1999.
32. Zock, P. L., M. B. Katan, and R. P.
Mensink, ‘‘Dietary Trans Fatty Acids and
Lipoprotein Cholesterol’’ [Letter to the
editor], American Journal of Clinical
Nutrition, 61:617, 1995.
33. Mensink, R. P., P. L. Zock, A. D. Kester,
et al., ‘‘Effects of Dietary Fatty Acids and
Carbohydrates on the Ratio of Serum
Total to HDL Cholesterol and on Serum
Lipids and Apolipoproteins: A MetaAnalysis of 60 Controlled Trials,’’
American Journal of Clinical Nutrition,
77:1146–1155, 2003.
34. Mozaffarian, D., M. B., Katan, A. Asherio,
et al., ‘‘Trans Fatty Acids and
Cardiovascular Disease,’’ New England
Journal of Medicine, 354:1601–1613,
2006.
35. Dourson, M. ‘‘Mode of Action and DoseResponse Evaluation of the Effect of
Partially Hydrogenated Oils on LDLCholesterol,’’ Presented at the SOT FDA
Colloquia on Emerging Toxicological
Science Challenges in Food and
Ingredient Safety, November 7, 2014.
36. National Research Council, Science and
Decisions: Advancing Risk Assessment,
National Academies Press, Washington,
DC, 2009; https://www.nap.edu).
37. Keys, A., J. T. Anderson, F. Grande,
‘‘Serum Cholesterol Response to Changes
in the Diet: I. Iodine Value of Dietary Fat
Versus 2S–P,’’ Metabolism, 14:747–758,
1965.
38. Hegsted, D. M., R. B. McGandy, M. L.
Myers, et al., ‘‘Quantitative Effects of
Dietary Fat on Serum Cholesterol in
Man,’’ American Journal of Clinical
Nutrition, 17:281–295, 1965.
39. Keys, A. and R. W. Parlin, ‘‘Serum
Cholesterol Response to Changes in
Dietary Lipids,’’ American Journal of
Clinical Nutrition, 19:175–181, 1966.
40. Page, I. H., E. V. Allen, F. L. Chamberlain,
et al., ‘‘Dietary Fat and Its Relation to
Heart Attacks and Strokes,’’ Circulation,
23:133–136, 1961.
41. Clarke, R., C. Frost, R. Collins, et al.
‘‘Dietary Lipids and Blood Cholesterol:
Quantitative Meta-Analysis of Metabolic
Ward Studies,’’ BMJ, 314:112–117, 1997.
42. Mensink R. P. and M. B. Katan, ‘‘Effect
of Dietary Fatty Acids on Serum Lipids
and Lipoproteins. A Meta-Analysis of 27
Trials,’’ Arteriosclerosis, Thrombosis,
and Vascular Biology, 12:911–919, 1992.
43. Reeves, R. M., ‘‘Effect of Dietary Trans
Fatty Acids on Cholesterol Levels’’
[Letter to the editor], New England
Journal of Medicine, 324:338–339, 1991.
44. Katan M. B., P. L. Zock, R. P. Mensink,
‘‘Trans Fatty Acids and their Effects on
Lipoproteins in Humans,’’ Annual
Review of Nutrition, 15:473–493, 1995.
45. Zock P. L. and R. P. Mensink, ‘‘Dietary
Trans-Fatty Acids and Serum
Lipoproteins in Humans,’’ Current
Opinion in Lipidology, 7:34–37, 1996.
46. Oh, K., F. B. Hu, J. E. Manson, et al.,
‘‘Dietary Fat Intake and Risk of Coronary
VerDate Sep<11>2014
18:47 Jun 16, 2015
Jkt 235001
Heart Disease in Women: 20 Years of
Follow-up of the Nurses’ Health Study,’’
American Journal of Epidemiology,
161:672–679, 2005.
47. Ascherio A., E. B. Rimm, E. L.
Giovannucci, et al., ‘‘Dietary Fat and
Risk of Coronary Heart Disease in Men:
Cohort Follow Up Study in the United
States,’’ BMJ, 313:84–90, 1996.
48. Willett W. C., M. J. Stampfer, J. E.
Manson, et al., ‘‘Intake of Trans Fatty
Acids and Risk of Coronary Heart
Disease Among Women,’’ Lancet,
341:581–585, 1993.
49. Hu, F. B., M. J. Stampfer, J. E. Manson,
et al., ‘‘Dietary Fat Intake and the Risk
of Coronary Heart Disease in Women,’’
New England Journal of Medicine,
337:1491–1499, 1997.
50. Pietinen, P., A. Ascherio, P. Korhonen, et
al., ‘‘Intake of Fatty Acids and Risk of
Coronary Heart Disease in a Cohort of
Finnish Men. The Alpha-Tocopherol,
Beta-Carotene Cancer Prevention Study,’’
American Journal of Epidemiology,
145:876–887, 1997.
51. Oomen, C. M., M. C. Ocke, E. J. Feskens,
et al., ‘‘Association Between Trans Fatty
Acid Intake and 10-year Risk of Coronary
Heart Disease in the Zutphen Elderly
Study: A Prospective Population-Based
Study,’’ Lancet, 357:746–751, 2001.
52. Mozaffarian D., A. Aro, W. C. Willett,
‘‘Health Effects of Trans-fatty Acids:
Experimental and Observational
Evidence,’’ European Journal of Clinical
Nutrition, 63:S5–21, 2009.
53. Skeaff C. M. and J. Miller, ‘‘Dietary Fat
and Coronary Heart Disease: Summary of
Evidence from Prospective Cohort and
Randomised Controlled Trials,’’ Annals
of Nutrition & Metabolism, 55:173–201,
2009.
54. Bendsen N. T., R. Christensen, E. M.
Bartels, et al., ‘‘Consumption of
Industrial and Ruminant Trans Fatty
Acids and Risk of Coronary Heart
Disease: A Systematic Review and Metaanalysis of Cohort Studies,’’ European
Journal of Clinical Nutrition, 65:773–
783, 2011.
55. Chowdhury R., S. Warnakula, S.
Kunutsor, et al., ‘‘Association of Dietary,
Circulating, and Supplement Fatty Acids
with Coronary Risk. A Systematic
Review and Meta-analysis,’’ Annals of
Internal Medicine, 160:398–406, 2014.
56. Trumbo, P. R. and T. Shimakawa,
‘‘Tolerable Upper Intake Levels for Trans
Fat, Saturated Fat, and Cholesterol,’’
Nutrition Reviews, 69:270–278, 2011.
57. Willett W. C., ‘‘Dietary Fats and Coronary
Heart Disease,’’ Journal of Internal
Medicine, 272:13–24, 2012.
58. National Heart, Lung, and Blood Institute,
‘‘Lifestyle Interventions to Reduce
Cardiovascular Risk: Systematic
Evidence Review From the Lifestyle
Work Group,’’ Bethesda, MD: HHS,
National Institutes of Health, 2013
(https://www.nhlbi.nih.gov/health-pro/
guidelines/in-develop/cardiovascularrisk-reduction/lifestyle).
59. Burlingame B., C. Nishida, R. Uauy, et al.,
‘‘Fats and Fatty Acids in Human
Nutrition: Introduction,’’ Annals of
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Nutrition & Metabolism, 55:5–7, 2009.
60. Uauy, R., A. Aro, R. Clarke, et al., ‘‘WHO
Scientific Update on Trans Fatty Acids:
Summary and Conclusions,’’ European
Journal of Clinical Nutrition, 63: S68–
S75, 2009.
61. Food and Agricultural Organization of the
United Nations (FAO) and WHO, Fats
and Fatty Acids in Human Nutrition.
Report of an Expert Consultation. Rome:
FAO; 2010.
62. Eckel, R. H., J. M. Jakicic, J. D. Ard, et
al. ‘‘2013 AHA/ACC Guideline on
Lifestyle Management to Reduce
Cardiovascular Risk: A Report of the
American College of Cardiology/
American Heart Association Task Force
on Practice Guidelines,’’ Circulation,
129:S76–S99, 2014.
63. European Food Safety Authority (EFSA),
‘‘Opinion of the Scientific Panel on
Dietetic Products, Nutrition and
Allergies on a Request from the
Commission Related to the Presence of
Trans Fatty Acids in Foods and the
Effect on Human Health of the
Consumption of Trans Fatty Acids,’’
EFSA Journal, 81:1–49, 2004.
64. Dietary Guidelines Advisory Committee,
Report of the Dietary Guidelines
Advisory Committee on Dietary
Guidelines for Americans, 2005,
Washington, DC: HHS, 2005; https://
www.health.gov/dietaryguidelines/
dga2005/report/default.htm.
65. Dietary Guidelines Advisory Committee,
Report of the Dietary Guidelines
Advisory Committee on Dietary
Guidelines for Americans, 2010,
Washington, DC: USDA, Agricultural
Research Service, 2010; https://
origin.www.cnpp.usda.gov/DGAs2010–
DGACReport.htm.
66. Memorandum from M. Pfeil to M.
Honigfort, June 11, 2015.
Dated: June 12, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–14883 Filed 6–16–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0369]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Regulations Under
the Federal Import Milk Act
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
SUMMARY:
E:\FR\FM\17JNN1.SGM
17JNN1
Federal Register / Vol. 80, No. 116 / Wednesday, June 17, 2015 / Notices
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by July 17,
2015.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0212. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Road; COLE–14526, Silver
Spring, MD 20993–0002 PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
34671
and plants producing milk and/or cream
to be shipped to the United States.
Section 1210.12 requires reports on the
physical examination of herds, while
§ 1210.13 requires the reporting of
tuberculin testing of the herds. In
addition, the regulations in part 1210
require that dairy farmers and plants
maintain pasteurization records
(§ 1210.15) and that each container of
milk or cream imported into the United
States bear a tag with the product type,
permit number, and shipper’s name and
address (§ 1210.22). Section 1210.20
requires that an application for a permit
to ship or transport milk or cream into
the United States be made by the actual
shipper. Section 1210.23 allows permits
to be granted based on certificates from
accredited officials.
In the Federal Register of March 25,
2015 (80 FR 15794), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. No comments were
received in response to the notice.
We estimate the burden of this
collection of information as follows:
collection of information to OMB for
review and clearance.
Under Federal Import Milk Act
(FIMA) (21 U.S.C. 141–149), milk or
cream may be imported into the United
States only by the holder of a valid
import milk permit (21 U.S.C. 141).
Before such permit is issued: (1) All
cows from which import milk or cream
is produced must be physically
examined and found healthy; (2) if the
milk or cream is imported raw, all such
cows must pass a tuberculin test; (3) the
dairy farm and each plant in which the
milk or cream is processed or handled
must be inspected and found to meet
certain sanitary requirements; (4)
bacterial counts of the milk at the time
of importation must not exceed
specified limits; and (5) the temperature
of the milk or cream at time of
importation must not exceed 50 °F (21
U.S.C. 142).
Our regulations in part 1210 (21 CFR
part 1210) implement the provisions of
FIMA. Sections 1210.11 and 1210.14
require reports on the sanitary
conditions of, respectively, dairy farms
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
responses per
respondent
21 CFR
Section
Form No.
1210.11 ........
FDA 1996; Sanitary Inspection
of Dairy Farms.
FDA 1995; Physical Examination of Cows.
FDA 1994; Tuberculin Test ......
FDA 1997; Sanitary Inspections
of Plants.
FDA 1993; Application for Permit.
FDA 1815; Permits Granted on
Certificates.
2
200
400
1.5 ...................................
600
1
1
1
0.5 (30 minutes) .............
0.5
1
2
1
1
1
2
0.5 (30 minutes) .............
2 ......................................
0.5
4
2
1
2
0.5 (30 minutes) .............
1
2
1
2
0.5 (30 minutes) .............
1
...................................................
........................
........................
........................
.........................................
607
1210.12 ........
1210.13 ........
1210.14 ........
1210.20 ........
1210.23 ........
Total ......
1 There
Number of
respondents
Total annual
responses
Average burden per
response
Total hours
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
21 CFR Section
Number of
respondents
Number of
responses per
respondent
Total annual
responses
Average burden
per response
Total hours
1210.15 ............................................................
2
1
2
0.05
0.1
asabaliauskas on DSK5VPTVN1PROD with NOTICES
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
The estimated number of respondents
and hours per response are based on our
experience with the import milk permit
program and the average number of
import milk permit holders over the
past three years. We estimate that two
respondents will submit approximately
200 Form FDA 1996 reports annually,
for a total of 600 responses. We estimate
the reporting burden to be 1.5 hours per
VerDate Sep<11>2014
18:47 Jun 16, 2015
Jkt 235001
response, for a total burden of 607
hours.
The Secretary of Health and Human
Services has the discretion to allow
Form FDA 1815, a duly certified
statement signed by an accredited
official of a foreign government, to be
submitted in lieu of Forms FDA 1994
and 1995. To date, Form FDA 1815 has
been submitted in lieu of these forms.
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Because we have not received any
Forms FDA 1994 and 1995 in the last 3
years, the Agency estimates no more
than one will be submitted annually.
We estimate the reporting burden for
each to be 0.5 hours per response for a
total burden reporting burden of 0.5
hours each.
We estimate that two respondents will
submit one Form FDA 1997 report
E:\FR\FM\17JNN1.SGM
17JNN1
34672
Federal Register / Vol. 80, No. 116 / Wednesday, June 17, 2015 / Notices
annually, for a total of two responses.
We estimate the reporting burden to be
2 hours per response, for a total burden
of 4 hours. We estimate that two
respondents will submit one Form FDA
1993 report annually, for a total of two
responses. We estimate the reporting
burden to be 0.5 hours per response, for
a total burden of 1 hour. We estimate
that two respondents will submit one
Form FDA 1815 report annually, for a
total of two responses. We estimate the
reporting burden to be 0.5 hours per
response, for a total burden of 1 hour.
With regard to records maintenance,
we estimate that approximately two
recordkeepers will spend 0.05 hours
annually maintaining the additional
pasteurization records required by
§ 1210.15, for a total of 0.10 hours
annually.
No burden has been estimated for the
tagging requirement in § 1210.22
because the information on the tag is
either supplied by us (permit number)
or is disclosed to third parties as a usual
and customary part of the shipper’s
normal business activities (type of
product, shipper’s name and address).
Under 5 CFR 1320.3(c)(2), the public
disclosure of information originally
supplied by the Federal Government to
the recipient for the purpose of
disclosure to the public is not subject to
review by the Office of Management and
Budget under the Paperwork Reduction
Act. Under 5 CFR 1320.3(b)(2)), the
time, effort, and financial resources
necessary to comply with a collection of
information are excluded from the
burden estimate if the reporting,
recordkeeping, or disclosure activities
needed to comply are usual and
customary because they would occur in
the normal course of business activities.
Dated: June 11, 2015.
Leslie Kux,
Associate Commissioner for Policy.
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled,
‘‘Food and Cosmetic Export Certificate
Applications Process’’ has been
approved by the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002,
PRAStaff@fda.hhs.gov.
SUMMARY:
On April
23, 2015, the Agency submitted a
proposed collection of information
entitled, ‘‘Food and Cosmetic Export
Certificate Applications Process’’ to
OMB for review and clearance under 44
U.S.C. 3507. An Agency may not
conduct or sponsor, and a person is not
required to respond to, a collection of
information unless it displays a
currently valid OMB control number.
OMB has now approved the information
collection and has assigned OMB
control number 0910–0793. The
approval expires on May 31, 2018. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
SUPPLEMENTARY INFORMATION:
Dated: June 11, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–14879 Filed 6–16–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1794]
Food and Drug Administration
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Impact of Ad
Exposure Frequency on Perception
and Mental Processing of Risk and
Benefit Information in Direct-toConsumer Prescription Drug Ads
[Docket No. FDA–2014–N–2347]
AGENCY:
[FR Doc. 2015–14888 Filed 6–16–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration,
asabaliauskas on DSK5VPTVN1PROD with NOTICES
HHS.
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Food and Cosmetic Export Certificate
Applications Process
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
VerDate Sep<11>2014
18:47 Jun 16, 2015
Jkt 235001
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
SUMMARY:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Fax written comments on the
collection of information by July 17,
2015.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910-New and
title ‘‘Impact of Ad Exposure Frequency
on Perception and Mental Processing of
Risk and Benefit Information in DirectTo-Consumer Prescription Drug Ads.’’
Also include the FDA docket number
found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
DATES:
Impact of Ad Exposure Frequency on
Perception and Mental Processing of
Risk and Benefit Information in Directto-Consumer Prescription Drug Ads;
OMB Control Number 0910–NEW
Section 1701(a)(4) of the Public
Health Service Act (42 U.S.C.
300u(a)(4)) authorizes the FDA to
conduct research relating to health
information. Section 1003(d)(2)(C) of the
Federal Food, Drug, and Cosmetic Act
(the FD&C Act) (21 U.S.C. 393(b)(2)(c))
authorizes FDA to conduct research
relating to drugs and other FDAregulated products in carrying out the
provisions of the FD&C Act.
In a typical promotional campaign,
consumers may be exposed to a directto-consumer (DTC) prescription drug ad
any number of times. Perceptual and
cognitive effects of increased ad
exposure frequency have been studied
extensively using non-drug ads. For
instance, one study demonstrated that a
commercial message repeated twice
generates better recall than a message
broadcast only once (Ref. 1). Another
study demonstrated that increased ad
exposures improve product attitudes
and recall for product attributes,
particularly when the substance of the
repeat messages is varied (Ref. 2).
Generally, it has been argued that first
exposure to an ad results in attention,
second exposure affects learning of the
advertised message, and third and
E:\FR\FM\17JNN1.SGM
17JNN1
Agencies
[Federal Register Volume 80, Number 116 (Wednesday, June 17, 2015)]
[Notices]
[Pages 34670-34672]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14888]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0369]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Regulations Under the
Federal Import Milk Act
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget
[[Page 34671]]
(OMB) for review and clearance under the Paperwork Reduction Act of
1995.
DATES: Fax written comments on the collection of information by July
17, 2015.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-0212.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Road; COLE-14526, Silver
Spring, MD 20993-0002 PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Under Federal Import Milk Act (FIMA) (21 U.S.C. 141-149), milk or
cream may be imported into the United States only by the holder of a
valid import milk permit (21 U.S.C. 141). Before such permit is issued:
(1) All cows from which import milk or cream is produced must be
physically examined and found healthy; (2) if the milk or cream is
imported raw, all such cows must pass a tuberculin test; (3) the dairy
farm and each plant in which the milk or cream is processed or handled
must be inspected and found to meet certain sanitary requirements; (4)
bacterial counts of the milk at the time of importation must not exceed
specified limits; and (5) the temperature of the milk or cream at time
of importation must not exceed 50[emsp14][deg]F (21 U.S.C. 142).
Our regulations in part 1210 (21 CFR part 1210) implement the
provisions of FIMA. Sections 1210.11 and 1210.14 require reports on the
sanitary conditions of, respectively, dairy farms and plants producing
milk and/or cream to be shipped to the United States. Section 1210.12
requires reports on the physical examination of herds, while Sec.
1210.13 requires the reporting of tuberculin testing of the herds. In
addition, the regulations in part 1210 require that dairy farmers and
plants maintain pasteurization records (Sec. 1210.15) and that each
container of milk or cream imported into the United States bear a tag
with the product type, permit number, and shipper's name and address
(Sec. 1210.22). Section 1210.20 requires that an application for a
permit to ship or transport milk or cream into the United States be
made by the actual shipper. Section 1210.23 allows permits to be
granted based on certificates from accredited officials.
In the Federal Register of March 25, 2015 (80 FR 15794), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received in response to the
notice.
We estimate the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR Section Form No. Number of responses per Total annual Average burden per Total hours
respondents respondent responses response
--------------------------------------------------------------------------------------------------------------------------------------------------------
1210.11............................ FDA 1996; Sanitary 2 200 400 1.5................... 600
Inspection of Dairy Farms.
1210.12............................ FDA 1995; Physical 1 1 1 0.5 (30 minutes)...... 0.5
Examination of Cows.
1210.13............................ FDA 1994; Tuberculin Test.. 1 1 1 0.5 (30 minutes)...... 0.5
1210.14............................ FDA 1997; Sanitary 2 1 2 2..................... 4
Inspections of Plants.
1210.20............................ FDA 1993; Application for 2 1 2 0.5 (30 minutes)...... 1
Permit.
1210.23............................ FDA 1815; Permits Granted 2 1 2 0.5 (30 minutes)...... 1
on Certificates.
--------------------------------------------------------------------------------------------------------------------
Total.......................... ........................... .............. .............. .............. ...................... 607
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
Table 2--Estimated Annual Recordkeeping Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR Section Number of responses per Total annual Average burden Total hours
respondents respondent responses per response
--------------------------------------------------------------------------------------------------------------------------------------------------------
1210.15.................................................. 2 1 2 0.05 0.1
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
The estimated number of respondents and hours per response are
based on our experience with the import milk permit program and the
average number of import milk permit holders over the past three years.
We estimate that two respondents will submit approximately 200 Form FDA
1996 reports annually, for a total of 600 responses. We estimate the
reporting burden to be 1.5 hours per response, for a total burden of
607 hours.
The Secretary of Health and Human Services has the discretion to
allow Form FDA 1815, a duly certified statement signed by an accredited
official of a foreign government, to be submitted in lieu of Forms FDA
1994 and 1995. To date, Form FDA 1815 has been submitted in lieu of
these forms. Because we have not received any Forms FDA 1994 and 1995
in the last 3 years, the Agency estimates no more than one will be
submitted annually. We estimate the reporting burden for each to be 0.5
hours per response for a total burden reporting burden of 0.5 hours
each.
We estimate that two respondents will submit one Form FDA 1997
report
[[Page 34672]]
annually, for a total of two responses. We estimate the reporting
burden to be 2 hours per response, for a total burden of 4 hours. We
estimate that two respondents will submit one Form FDA 1993 report
annually, for a total of two responses. We estimate the reporting
burden to be 0.5 hours per response, for a total burden of 1 hour. We
estimate that two respondents will submit one Form FDA 1815 report
annually, for a total of two responses. We estimate the reporting
burden to be 0.5 hours per response, for a total burden of 1 hour.
With regard to records maintenance, we estimate that approximately
two recordkeepers will spend 0.05 hours annually maintaining the
additional pasteurization records required by Sec. 1210.15, for a
total of 0.10 hours annually.
No burden has been estimated for the tagging requirement in Sec.
1210.22 because the information on the tag is either supplied by us
(permit number) or is disclosed to third parties as a usual and
customary part of the shipper's normal business activities (type of
product, shipper's name and address). Under 5 CFR 1320.3(c)(2), the
public disclosure of information originally supplied by the Federal
Government to the recipient for the purpose of disclosure to the public
is not subject to review by the Office of Management and Budget under
the Paperwork Reduction Act. Under 5 CFR 1320.3(b)(2)), the time,
effort, and financial resources necessary to comply with a collection
of information are excluded from the burden estimate if the reporting,
recordkeeping, or disclosure activities needed to comply are usual and
customary because they would occur in the normal course of business
activities.
Dated: June 11, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-14888 Filed 6-16-15; 8:45 am]
BILLING CODE 4164-01-P